The Gold Standard in Cardiac Risk Stratification ––– Detecting Myocardial Injury at the Molecular Level for Precise Prognosis ● Ultra-High Sensitivity and Early Diagnostic Capability ● Exceptional Analytical Precision and Standardization ● Clinical Prognosis and Risk Stratification Value Cardiology Department Nephrology Department Oncology Department Intensive Care Physical Unit, ICU Examinati

Introduction High-sensitivity cardiac troponin T (hs-cTnT) is a critical component of the regulatory protein complex governing myocardial contraction, primarily localized within the myofibrils of cardiomyocytes and existing in a bound ternary complex with cardiac troponin I (cTnI) and troponin C (cTnC). Clinically, dynamic serial measurements of hs-cTnT provide substantial prognostic value for evaluating cardiovascular outcomes, including risks of heart failure and sudden cardiac death. Clinical Significance High-sensitivity cardiac troponin T (hs-cTnT) is the gold standard for early detection...

Time to Initial Elevation Molecular Release:hs-cTnT circulates predominantly as intact ternary complexes (cTnI-cTnC-cTnT) and free monomers, whereas hs-cTnI exists as fragmented, post-translationally modified isoforms (oxidized, phosphorylated) with minimal intact monomer stability. Assay Standardization:hs-cTnT assays employ standardized epitopes across platforms, ensuring inter-assay comparability, while hs-cTnI assays exhibit variability due to inconsistent antibody targets (e.g., 1+1 vs. 2+2 designs), hindering harmonization. Diagnostic Accuracy: Both assays show comparable overall diagnostic...

Applicable System ^Poclight Nanjing Poclight Biotechnology Co., Ltd. Address: South Side, 2nd Floor, Building A02, Biopharmaceutical Valley Accelerator (Phase III), No. 142 Huakang Road, Jiangbei New District, Nanjing City, Jiangsu Province, 210000, P R. China E-mail: [email protected] Website: www.poclight.com